The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(5-Bromofuran-2-yl)-2-methyl-5-oxo-N-(o-tolyl)-1,4,5,6,7,8-hexahydroquinoline-3-carboxamide ID: ALA4547569
PubChem CID: 155553285
Max Phase: Preclinical
Molecular Formula: C22H21BrN2O3
Molecular Weight: 441.33
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC1=C(C(=O)Nc2ccccc2C)C(c2ccc(Br)o2)C2=C(CCCC2=O)N1
Standard InChI: InChI=1S/C22H21BrN2O3/c1-12-6-3-4-7-14(12)25-22(27)19-13(2)24-15-8-5-9-16(26)20(15)21(19)17-10-11-18(23)28-17/h3-4,6-7,10-11,21,24H,5,8-9H2,1-2H3,(H,25,27)
Standard InChI Key: VJJZMDYDXDGRAA-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
12.5674 -28.7420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5674 -29.5633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2768 -29.9719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2768 -28.3293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9862 -28.7420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9828 -29.5633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6889 -29.9768 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4031 -29.5693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4066 -28.7480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6959 -28.3342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2768 -27.5080 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.1085 -29.9860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1164 -28.3431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1207 -27.5218 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.8261 -28.7555 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.5401 -28.3506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2490 -28.7649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9625 -28.3607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9673 -27.5386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2526 -27.1223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5420 -27.5329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2435 -29.5821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6967 -27.5171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3592 -27.0386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1089 -26.2607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2916 -26.2584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0370 -27.0349 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.8131 -25.5959 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 1 0
3 6 1 0
5 4 1 0
5 6 2 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
4 11 2 0
8 12 1 0
9 13 1 0
13 14 2 0
13 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
17 22 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 23 1 0
10 23 1 0
26 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 441.33Molecular Weight (Monoisotopic): 440.0736AlogP: 4.96#Rotatable Bonds: 3Polar Surface Area: 71.34Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.16CX LogD: 3.16Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.71Np Likeness Score: -1.68
References 1. Ulven ER, Quon T, Sergeev E, Barki N, Brvar M, Hudson BD, Dutta P, Hansen AH, Bielefeldt LØ, Tobin AB, McKenzie CJ, Milligan G, Ulven T.. (2020) Structure-Activity Relationship Studies of Tetrahydroquinolone Free Fatty Acid Receptor 3 Modulators., 63 (7): [PMID:32141297 ] [10.1021/acs.jmedchem.9b02036 ]